Abstract:China has been widely criticised for its failure to respond to the HIV/AIDS threat and for systematic suppression of information about the size of the problem. 1 Asia Division, Human Rights WatchLocked doors: the human rights of people living with HIV/AIDS in China. Human Rights Watch. 2003; 15: 1-95 Google Scholar , 2 Ruger JP Democracy and health. Q J Med. 2005; 98: 299-304 Crossref Scopus (62) Google Scholar Thus Zunyou Wu and colleagues' report in today's Lancet of the way in which China has responded to HIV/AIDS will surprise many. 3 Wu ZY Sullivan S Wang Y Rotheram MJ Detels R Evolution of China's response to HIV/AIDS. Lancet. 2007; 369: 679-690 Summary Full Text Full Text PDF PubMed Scopus (400) Google Scholar Their thorough review shows how much progress has been made, and how, given the political and cultural context, the Chinese response has evolved in a measured and mainly appropriate way. Public health versus political frontiersRarely has an issue of The Lancet so well reflected the lack of respect shown by microorganisms to national and international frontiers. When economies are threatened, motivation to find solutions is increased, as was illustrated by the control of the epidemic of severe acute respiratory syndrome (SARS) in 2003 in China. But the scales of the HIV/AIDS and tuberculosis epidemics, particularly in Asia, warrant an aggressive and committed approach to strengthening health systems and to facilitating international collaboration in disease control. Full-Text PDF HIV-1 in TaiwanTaiwan is entering a new and dangerous phase of its HIV-1/AIDS epidemic. By the end of 2006, 13 702 individuals (including 599 foreigners) had been reported as infected with HIV-1 to the Centers for Disease Control of Taiwan.1 In 2003, HIV-1 rates in first-time blood donors, military conscripts, and pregnant women were measured at 5·2, 57·0, and 12·0 per 100 000, respectively.1 Data from that year indicated HIV-1 rates of 0·09% for intravenous drug users, 0·2% for female sex workers, 1·9% for patients with sexually transmitted infections, and 6·7% for men who have sex with men in saunas or bath houses. Full-Text PDF Evolution of China's response to HIV/AIDSFour factors have driven China's response to the HIV/AIDS pandemic: (1) existing government structures and networks of relationships; (2) increasing scientific information; (3) external influences that underscored the potential consequences of an HIV/AIDS pandemic and thus accelerated strategic planning; and (4) increasing political commitment at the highest levels. China's response culminated in legislation to control HIV/AIDS—the AIDS Prevention and Control Regulations. Three major initiatives are being scaled up concurrently. Full-Text PDF

China Needs Safe and Effective Microbicides for Preventing Sexual Transmission of HIV

Microbicides: Stopping HIV at the Gate

Microbicide-A New Approach to Prevent HIV Transmission

Controlling HIV Sexual Transmission: a Major Challenge for China’s New Leadership

Progress in the research of topical microbicides against HIV

Microbicides: a new hope for HIV prevention

Prevention and control of HIV/AIDS in China: lessons from the past three decades

The Increase of Sexually Transmitted Infections Calls for Simultaneous Preventive Intervention for More Effectively Containing HIV Epidemics in China.

HIV/AIDS in China: the Numbers Problem

The epidemic of major sexually transmitted diseases in Shanghai, China, 2009-2018.

'Getting to zero' in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention

Bring safe sex to China

Discussion on epidemic status and control strategies of HIV/AIDS

AIDS Treatment with Novel Anti-HIV Compounds Improved by Nanotechnology

HIV/AIDS responses in China should focus on the impact of global integration.

Challenges to eliminating the AIDS pandemic in China.

Critical issues for decreasing the mortality of human immunodeficiency virus/acquired immunodeficiency syndrome patients in China

Reduction in HIV Community Viral Loads Following the Implementation of a “treatment As Prevention” Strategy over 2 Years at a Population-Level among Men Who Have Sex with Men in Hangzhou, China

Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects

Strategy for AIDS Prevention and Treatment

CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases